imiquimod has been researched along with B-Cell Chronic Lymphocytic Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulai Livideanu, C; Casassa, EA; Fortenfant, F; Gaudin, C; Konstantinou, MP; Lamant, L; Mengelle, C; Nicol, P; Paul, C; Viraben, R | 1 |
| Anagnostopoulos, A; Belessi, C; Chartomatsidou, E; Chatzouli, M; Ghia, P; Kollia, P; Muzio, M; Ntoufa, S; Papakonstantinou, N; Stamatopoulos, K | 1 |
| Béné, MC; Bittencourt, Mde C; Chen, M; Faure, GC; Feugier, P | 1 |
| Grossman, L; Mena, J; Miller, RL; Shi, Y; Sorrenti, V; Spaner, DE | 1 |
| Bangsgaard, N; Skov, L | 1 |
| Germain, M; Skelton, H; Smith, KJ | 1 |
1 trial(s) available for imiquimod and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Caspase 8; Female; Humans; Imiquimod; Immunoglobulins; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Oligodeoxyribonucleotides; Receptors, Antigen, B-Cell; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2014 |
5 other study(ies) available for imiquimod and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Female; Foscarnet; Herpes Simplex; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Perineum | 2018 |
Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD19; Antineoplastic Agents; Apoptosis; CD5 Antigens; Cytokines; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Imiquimod; In Situ Nick-End Labeling; Interleukin-6; Interleukin-8; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Toll-Like Receptor 7; Tumor Cells, Cultured | 2012 |
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Disease Progression; Humans; Imiquimod; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome | 2005 |
Chronic genital ulceration due to herpes simplex infection treated successfully with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Chronic Disease; Female; Herpes Genitalis; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell | 2008 |
Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppression Therapy; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Ointments; Skin Neoplasms; Sulindac | 2001 |